Postoperative mortality after primary cytoreductive surgery for advanced stage epithelial ovarian cancer: A systematic review

被引:66
|
作者
Gerestein, Cornelis G. [1 ,3 ]
Damhuis, Ronald A. M. [2 ]
Burger, Curt W. [3 ]
Kooi, Geertruida S. [1 ]
机构
[1] Albert Schweitzer Hosp, Dept Obstet & Gynecol, Dordrecht, Netherlands
[2] Rotterdam Canc Registry, Rotterdam, Netherlands
[3] Univ Med Ctr, Daniel Den Hoed Erasmus MC, Dept Obstet & Gynecol, Div Gynecol Oncol, Rotterdam, Netherlands
关键词
Postoperative mortality; 30-day mortality; Ovarian cancer; Primary cytoreductive surgery; Advanced stage; PRIMARY PERITONEAL CANCER; NEOADJUVANT CHEMOTHERAPY; SURGICAL CYTOREDUCTION; GYNECOLOGIC ONCOLOGISTS; PRIMARY DEBULKING; BOWEL RESECTION; FALLOPIAN-TUBE; ELDERLY-WOMEN; CARCINOMA; SURVIVAL;
D O I
10.1016/j.ygyno.2009.03.011
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Objective. Accurate estimation of the risk of postoperative mortality (POM) is essential for the decision whether or not to perform cytoreductive surgery in a patient with advanced stage ovarian cancer. To ascertain modern reference figures, a systematic review of studies reporting POM after primary cytoreductive surgery for advanced stage epithelial ovarian cancer (EOC) was performed. Materials and methods. A Medline search was performed to retrieve papers on primary cytoreductive surgery for advanced stage EOC. Twenty-three papers met the inclusion criteria and were reviewed. Results. According to population-based studies, POM after primary cytoreductive surgery for EOC is 3.7% on average. Single centre studies report an average rate of 2.5%. The overall mean POM is 2.8%. POM is more frequent for elderly women and after extensive procedures. Accurate information on age-specific and procedure-specific rates could not be obtained. Conclusion. POM rates after surgery for EOC are satisfactorily low. There is a clear need for reliable reference figures for mortality after debulking surgery in the elderly. (C) 2009 Elsevier Inc. All rights reserved.
引用
收藏
页码:523 / 527
页数:5
相关论文
共 50 条
  • [41] PREDICTORS OF POSTOPERATIVE MORBIDITY AFTER CYTOREDUCTIVE SURGERY FOR ADVANCED OVARIAN CANCER: ANALYSIS AND MANAGEMENT OF COMPLICATIONS
    Di Donato, V.
    Di Pinto, A.
    Benedetti, E.
    Palaia, I.
    Perniola, G.
    Schiavi, M.
    Musella, A.
    Tomao, F.
    Muzii, L.
    Panici, P. Benedetti
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2019, 29 : A35 - A36
  • [42] Nomogram prediction model of severe postoperative complications after cytoreductive surgery for advanced ovarian cancer
    Cao, Gai Jing
    Wang, Xingguo
    Xu, Zhiyang
    Li, Ziyi
    Liu, Shujuan
    Fu, Yue
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2023, 33 (SUPPL_4) : A136 - A137
  • [43] PROGNOSTIC FACTORS FOLLOWING CYTOREDUCTIVE SURGERY FOR ADVANCED EPITHELIAL OVARIAN CANCER
    Martinez Lamela, Ester
    Molero Vilchez, Jesus
    Santiago Gomez, Angela
    Suarez Aguado, Judith
    Exposito Lucena, Yolanda
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2023, 33 : A267 - A268
  • [44] Prediction of Residual Disease After Primary Cytoreductive Surgery for Advanced-Stage Ovarian Cancer Accuracy of Clinical Judgment
    Gerestein, Cornelis G.
    van der Spek, Dirkina W.
    Eijkemans, Marinus J.
    Bakker, Jeanette
    Kooi, Geertruida S.
    Burger, Curt W.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2009, 19 (09) : 1511 - 1515
  • [45] Stuuy on the secondary cytoreductive surgery for patients with advanced ovarian epithelial cancer
    ZngRongyuZhngZhiyiTheCncerHospitloftheShnghiMediclUniversity AbstrctObjective TostudyonthesecondarycytoreductivesurgerySCRSforptientswithovrinepithelilcncerOECMethodsLiterturesaboutSCBSforptientswithdvncedOECfromtofoundinMEDLINE
    现代妇产科进展, 1999, (02) : 97 - 100
  • [46] Epithelial ovarian cancers and minimally invasive cytoreductive surgery after neoadjuvant chemotherapy: A systematic review
    Achen, G.
    Koual, M.
    Bentivegna, E.
    Fournier, L.
    Xuan, H. -T. Nguyen
    Delanoy, N.
    Bats, A. -S.
    Azais, H.
    GYNECOLOGIE OBSTETRIQUE FERTILITE & SENOLOGIE, 2021, 49 (10): : 736 - 743
  • [47] Splenectomy in the context of primary cytoreductive operations for advanced epithelial ovarian cancer
    Eisenkop, SM
    Spirtos, NM
    Lin, WCM
    GYNECOLOGIC ONCOLOGY, 2006, 100 (02) : 344 - 348
  • [48] Morbidity of rectosigmoid resection and primary anastomosis in patients undergoing primary cytoreductive surgery for advanced epithelial ovarian cancer
    Mourton, SM
    Temple, LK
    Abu-Rustum, NR
    Gemignani, ML
    Sonoda, Y
    Bochner, BH
    Barakat, RR
    Chi, DS
    GYNECOLOGIC ONCOLOGY, 2005, 99 (03) : 608 - 614
  • [49] UNCHANGED MORBIDITY DESPITE INCREASED SURGICAL RADICALITY IN CYTOREDUCTIVE SURGERY FOR AN ADVANCED STAGE EPITHELIAL OVARIAN CANCER
    Kaufmann, A.
    Laios, A.
    Broadhead, T.
    Hutson, R.
    Nugent, D.
    Thangavelu, A.
    Theophilou, G.
    De Jong, D.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2019, 29 : A455 - A455
  • [50] Predicting the Outcome of Cytoreductive Surgery for Advanced Ovarian Cancer A Review
    Ibeanu, Okechukwu A.
    Bristow, Robert E.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2010, 20 : S1 - S11